209 related articles for article (PubMed ID: 25048966)
1. Cytochrome P450 1A1 (CYP1A1) polymorphism and susceptibility to esophageal cancer: an updated meta-analysis of 27 studies.
Gong FF; Lu SS; Hu CY; Qian ZZ; Feng F; Wu YL; Yang HY; Sun YH
Tumour Biol; 2014 Oct; 35(10):10351-61. PubMed ID: 25048966
[TBL] [Abstract][Full Text] [Related]
2. [Study on the association of cytochrome P450 polymorphisms and the risk of esophageal cancer: a meta-analysis].
Dai LP; Wang YP; Wu XB; Wang KJ; Lv QJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Nov; 30(11):1198-202. PubMed ID: 20193595
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of association studies of CYP1A1 genetic polymorphisms with digestive tract cancer susceptibility in Chinese.
Liu C; Jiang Z; Deng QX; Zhao YN
Asian Pac J Cancer Prev; 2014; 15(11):4689-95. PubMed ID: 24969905
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms of cytochrome P4501A1 and oesophageal squamous-cell carcinoma in Taiwan.
Wu MT; Lee JM; Wu DC; Ho CK; Wang YT; Lee YC; Hsu HK; Kao EL
Br J Cancer; 2002 Aug; 87(5):529-32. PubMed ID: 12189551
[TBL] [Abstract][Full Text] [Related]
5. Interactions between CYP1A1 polymorphisms and cigarette smoking are associated with the risk of hepatocellular carcinoma: evidence from epidemiological studies.
Yu L; Sun L; Jiang YF; Lu BL; Sun DR; Zhu LY
Mol Biol Rep; 2012 Jun; 39(6):6641-6. PubMed ID: 22297691
[TBL] [Abstract][Full Text] [Related]
6. The effect of CYP1A1 polymorphisms on the risk of lung cancer: a global meta-analysis based on 71 case-control studies.
Chen Z; Li Z; Niu X; Ye X; Yu Y; Lu S; Chen Z
Mutagenesis; 2011 May; 26(3):437-46. PubMed ID: 21402622
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 1A1 Ile462Val polymorphism and oral carcinoma risk: an updated meta-analysis including 1,515 cases and 2,233 controls.
Zhuo X; Zhao H; Chang A; Ye H; Zhou Y; Song Y; Tan Y
Tumour Biol; 2012 Dec; 33(6):2079-89. PubMed ID: 22847262
[TBL] [Abstract][Full Text] [Related]
8. The cytochrome P4501A1 gene polymorphisms and endometriosis: a meta-analysis.
Fan W; Huang Z; Xiao Z; Li S; Ma Q
J Assist Reprod Genet; 2016 Oct; 33(10):1373-1383. PubMed ID: 27525656
[TBL] [Abstract][Full Text] [Related]
9. CYP1A1 and CYP2E1 genotypes and risk of esophageal squamous cell carcinoma in a high-incidence region, Kashmir.
Bhat GA; Shah IA; Makhdoomi MA; Iqbal B; Rafiq R; Nabi S; Masood A; Lone MM; Dar NA
Tumour Biol; 2014 Jun; 35(6):5323-30. PubMed ID: 24504680
[TBL] [Abstract][Full Text] [Related]
10. Lack of association between the CYP1A1 Ile462Val polymorphism and endometrial cancer risk: a meta-analysis.
Wang XW; Zhong TY; Xiong YH; Lin HB; Liu QY
Asian Pac J Cancer Prev; 2012; 13(8):3717-21. PubMed ID: 23098461
[TBL] [Abstract][Full Text] [Related]
11. Association between CYP1A1 polymorphism and colorectal cancer risk: a meta-analysis.
Zheng Y; Wang JJ; Sun L; Li HL
Mol Biol Rep; 2012 Apr; 39(4):3533-40. PubMed ID: 21710246
[TBL] [Abstract][Full Text] [Related]
12. CYP1A1 gene polymorphism and risk of epithelial ovarian neoplasm.
Aktas D; Guney I; Alikasifoglu M; Yüce K; Tuncbilek E; Ayhan A
Gynecol Oncol; 2002 Aug; 86(2):124-8. PubMed ID: 12144816
[TBL] [Abstract][Full Text] [Related]
13. CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: an updated meta-analysis and review.
Zhan P; Wang Q; Qian Q; Wei SZ; Yu LK
J Exp Clin Cancer Res; 2011 Oct; 30(1):99. PubMed ID: 22014025
[TBL] [Abstract][Full Text] [Related]
14. Association between CYP1A1 polymorphisms and esophageal cancer: a meta-analysis.
Shen FF; Zhou FY; Xue QS; Pan Y; Zheng L; Zhang H; Wang LD; Zheng HF
Mol Biol Rep; 2013 Oct; 40(10):6035-42. PubMed ID: 24065535
[TBL] [Abstract][Full Text] [Related]
15. Association between CYP1A1 Ile462Val variation and acute leukemia risk: meta-analyses including 2164 cases and 4160 controls.
Zhuo W; Zhang L; Zhu B; Qiu Z; Chen Z
PLoS One; 2012; 7(10):e46974. PubMed ID: 23056546
[TBL] [Abstract][Full Text] [Related]
16. Associations between genetic polymorphisms of Phase I and II metabolizing enzymes, p53 and susceptibility to esophageal adenocarcinoma.
Casson AG; Zheng Z; Chiasson D; MacDonald K; Riddell DC; Guernsey JR; Guernsey DL; McLaughlin J
Cancer Detect Prev; 2003; 27(2):139-46. PubMed ID: 12670526
[TBL] [Abstract][Full Text] [Related]
17. [Association of CYP1A1 Ile462Val polymorphisms with susceptibility to small cell lung cancer].
He B; Lin J; Cao L; Wang H; Rao J; Liu Y; Zhang Z
Wei Sheng Yan Jiu; 2014 May; 43(3):393-6, 418. PubMed ID: 24964616
[TBL] [Abstract][Full Text] [Related]
18. Phase I/II enzyme gene polymorphisms and esophageal cancer risk: a meta-analysis of the literature.
Yang CX; Matsuo K; Wang ZM; Tajima K
World J Gastroenterol; 2005 May; 11(17):2531-8. PubMed ID: 15849806
[TBL] [Abstract][Full Text] [Related]
19. GST, NAT1, CYP1A1 polymorphisms and risk of esophageal and gastric adenocarcinomas.
Wideroff L; Vaughan TL; Farin FM; Gammon MD; Risch H; Stanford JL; Chow WH
Cancer Detect Prev; 2007; 31(3):233-6. PubMed ID: 17646057
[TBL] [Abstract][Full Text] [Related]
20. CYP1A1 Ile462Val polymorphism contributes to lung cancer susceptibility among lung squamous carcinoma and smokers: a meta-analysis.
Ji YN; Wang Q; Suo LJ
PLoS One; 2012; 7(8):e43397. PubMed ID: 22952673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
